房颤与慢性肾病患者肾功能下降的关联
这项基于医院的回顾性队列研究纳入2008至2018年≥20岁慢性肾病患者,按倾向评分将房颤患者与非房颤对照按1:2匹配,分析房颤与eGFR下降及终末期肾病的关联。结果显示房颤组eGFR下降≥20%至≥50%及ESRD风险均更高,且CHA2DS2-VASc评分越高风险越大。
要点
- 房颤与CKD患者eGFR下降≥20%至≥50%及ESRD风险升高相关。
- CHA2DS2-VASc评分较高者肾功能下降和ESRD风险更大。
- CHA2DS2-VASc评分或可用于CKD合并房颤患者的肾脏风险分层。
核心结论
- 在慢性肾病患者中,房颤与随后肾功能下降及终末期肾病风险升高相关。
- CHA2DS2-VASc评分可能是预测肾功能下降风险的有用风险分层工具。
研究设计与样本
- 回顾性医院队列研究,纳入2008年1月1日至2018年12月31日年龄≥20岁的慢性肾病患者。
主要发现
- 房颤组eGFR下降≥20%风险HR 1.43(95%CI 1.33至1.53),≥30%风险HR 1.50(95%CI 1.36至1.66)。
- 房颤组eGFR下降≥40%风险HR 1.62(95%CI 1.41至1.85),≥50%风险HR 1.82(95%CI 1.50至2.20)。
- 房颤组终末期肾病风险HR 1.22(95%CI 1.12至1.34)。
- 较高的CHA2DS2-VASc评分与eGFR下降和ESRD风险增加相关。
临床怎么用
- 对CKD合并房颤患者应关注肾功能下降风险,可结合CHA2DS2-VASc评分进行肾脏风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic kidney disease (CKD) is known to increase the risk of atrial fibrillation (AF) development, but the relationship between AF and subsequent renal function decline in patients with CKD is not well understood. In this study, we explored the role of AF on renal outcomes among patients with CKD. METHODS: In a retrospective hospital-based cohort study, we identified patients with CKD aged ≥20 years from 1 January 2008 to 31 December 2018. The patients were divided into AF and non-AF groups. We matched each patient with CKD and AF to two non-AF CKD controls according to propensity scores. The outcomes of interest included estimated glomerular filtration rate (eGFR) decline of ≥20%, ≥30%, ≥40% and ≥50%, and end-stage renal disease (ESRD). RESULTS: After propensity score matching, 6731 patients with AF and 13 462 matched controls were included in the analyses. Compared with the non-AF group, the AF group exhibited greater risks of eGFR decline ≥20% (HR 1.43; 95% CI 1.33 to 1.53), ≥30% (HR 1.50; 95% CI 1.36 to 1.66), ≥40% (HR 1.62; 95% CI 1.41 to 1.85) and ≥50% (HR 1.82; 95% CI 1.50 to 2.20), and ESRD (HR 1.22; 95% CI 1.12 to 1.34). Higher CHA2DS2-VASc scores were associated with greater risks of eGFR decline and ESRD. CONCLUSIONS: In patients with CKD, AF was associated with greater risks of subsequent renal function decline. CHA2DS2-VASc scores may be a useful risk stratification scheme for predicting the risk of renal function decline.
引用
- Chen TH, Chu YC, Ou SM, et al. Associations of atrial fibrillation with renal function decline in patients with chronic kidney disease. Heart. 2021. PMID: 34193464. doi:10.1136/heartjnl-2021-319297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。